Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening

Novel technologies that include recombinant pathogens and rapid detection methods are contributing to the development of drugs for neglected diseases. Recently, the results from the first high throughput screening (HTS) to test compounds for activity against Trypanosoma cruzi trypomastigote infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Andriani, Grasiella, Chessler, Anne-Danielle C., Courtemanche, Gilles, Burleigh, Barbara A., Rodriguez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166044/
https://www.ncbi.nlm.nih.gov/pubmed/21912715
http://dx.doi.org/10.1371/journal.pntd.0001298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166044/
https://www.ncbi.nlm.nih.gov/pubmed/21912715
http://dx.doi.org/10.1371/journal.pntd.0001298

Ejemplares similares